An Interview with Dr. Jim Mault, CEO and Chairman at BioIntelliSense

ATA President Joe Kvedar recently had a conversation with Jim Mault, the CEO and Chairman of BioIntelliSense.  They spoke about the ground-breaking work his company is doing in RPM and COVID-19 symptom monitoring, Jim’s role as chair of our new Decentralized Clinical Trials Special Interest Group, and the insights he’s gained throughout his 35 years as an innovator, creator, and thought leader in the virtual health space.